Navigation Links
EULAR issues updated rheumatoid arthritis management recommendations
Date:7/3/2013

The European League Against Rheumatism (EULAR) has released updated recommendations for the management of RA. According to this latest guidance, treatment with disease-modifying anti-rheumatic drugs (DMARDs) should be initiated as soon as a diagnosis of RA is made, with the aim of reaching a target of remission or low disease activity in every patient.

As first-line treatment, EULAR recommends rheumatologists administer methotrexate (MTX) or combination therapy of MTX with other conventional synthetic DMARDs. Low-dose glucocorticoids should also be considered in combination with DMARDs for up to six months, but should be tapered as soon as clinically feasible.

"These recommendations were based on three extensive literature reviews of the efficacy and safety of biological and conventional DMARDs, and address a number of common misinterpretations of the 2010 guidelines," according to Professor Josef Smolen, Medical University of Vienna and Hietzing Hospital, Vienna. "As already stated in 2010, by advocating the use of synthetic DMARDs, rather than biologics, as the first-line treatment this approach avoids the over-treatment of 20-50% of patients with early RA, who will achieve the treatment target with such initial therapy" he concluded for the Task Force.

However, in patients failing to respond to this treatment within 6 months and when poor prognostic factors are present, biological DMARDs (TNF-inhibitors, abatacept or tocilizumab or under certain circumstances rituximab) should be administered in combination with MTX.

The document further recommends that patients who have failed to respond to an initial biologic DMARD should receive another biologic DMARD. Patients who have failed to respond to an initial TNF-inhibitor may receive another TNF-inhibitor, or a biologic with an alternative mode of action. If biologic treatment has failed, tofacitinib may be considered where approved.

"Although the European Medicin
'/>"/>

Contact: EULAR Press Office
eularpressoffice@cohnwolfe.com
44-020-733-15364
European League Against Rheumatism
Source:Eurekalert

Page: 1 2

Related medicine news :

1. UCSF chancellor issues call-to-arms to patient advocates
2. Radiologists rank themselves as less than competent on health policy issues
3. Genetic abnormalities in benign or malignant tissues predict relapse of prostate cancer
4. FDA Issues Multiple Sclerosis Drug Alert
5. Quality of care, other issues may cause worse results in black prostate cancer surgery patients
6. U.S. Task Force Issues Blood Pressure Guidelines
7. Internists in Washington to discuss patient and professional issues in meetings on Capitol Hill
8. Cheaper drug could lead to serious eye issues
9. Insulite Labs announces the launch of the PCOS Inspiration Hour, a one hour virtual gathering place for women with PCOS and other women’s health issues to come together.
10. LawyersandSettlements.com Issues Report on Prostate Health Claim Lawsuits and Propecia Side Effect Litigation
11. What Men Should Know About Veins: Varicose Veins and Venous Disease are Real Medical Issues
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/21/2014)... Nov. 20, 2014 (HealthDay News) -- The cost of ... percent in recent years, climbing to more than $322 ... increases in cost were seen with prediabetes care, which ... jumped 82 percent, the researchers added. In 2012, ... totaled more than $1,000 for every American. That total ...
(Date:11/21/2014)... 2014 (HealthDay News) -- Scientists say they,ve mapped the genome ... a British man,s brain, in hopes it might help others ... in the journal Genome Biology , the tapeworm was ... Chinese ethnicity. "This infection is so rare worldwide and ... diagnosed ... until the worm was pulled out from the ...
(Date:11/21/2014)... IN (PRWEB) November 21, 2014 MLF ... dogs and cats . Liv-Pro® Probiotics for Pets helps ... balance back to a pet's intestinal flora after it ... treatment. , Liv-Pro Probiotics for Pets is a ... additives. It contains seven live active bacteria strains that ...
(Date:11/21/2014)... 2014 Saint Luke’s Mid America ... Guidelines®–Heart Failure Gold-Plus Quality Achievement Award for implementing ... Heart Association/American College of Cardiology Foundation in their ... Get With The Guidelines–Heart Failure is a quality ... most up-to-date, research-based guidelines with the goal of ...
(Date:11/21/2014)... Orange County, CA (PRWEB) November 21, 2014 ... be featured in an upcoming episode of Innovations with ... 2015. Dates and show times TBA. , Big Bud ... with information for growing, harvesting, and utilization of medical ... look at Big Bud Farms’ wide variety of products ...
Breaking Medicine News(10 mins):Health News:Cost of Diabetes Care Keeps Climbing, Report Shows 2Health News:Ick! Tapeworm Infecting Man's Brain Yields Genetic Secrets 2Health News:MLF Biotech Introduces Liv-Pro Probiotics for Pets 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 2Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 3Health News:Saint Luke’s Mid America Heart Institute Awarded Get With The Guidelines Heart Failure Gold-Plus Quality Achievement Award 4Health News:Big Bud Farms to be Featured in Upcoming Episode of Innovations with Ed Begley Jr. 2
... be harmful, researchers warn , WEDNESDAY, Nov. 11 (HealthDay News) ... floors comes from outdoors and can pose a health threat, ... model that can track the distribution of outdoor soil and ... percent of household dust originates from tracked-in soil and airborne ...
... Afghanistan and Iraq are placing unprecedented pressures on today,s soldiers, ... The tragedy last week at Fort Hood, Texas, where an ... 13 people and wounding 29 others in a shooting rampage, ... in Afghanistan and Iraq, but also on another casualty of ...
... ... at this year,s Molecular Medicine Tri-Conference, is the inspiration for a new film which ... ... -- Cambridge Healthtech Institute,s (CHI) flagship event, the Molecular Medicine Tri-Conference (February 3-5, 2010) ...
... are in U.S. dollars , QUEBEC CITY, Nov. 11 /PRNewswire-FirstCall/ ... a global biopharmaceutical company focused on endocrinology and oncology, today ... three-month and nine-month periods ended September 30, 2009. , , ... - July 7, 2009. Publication in Proceedings of the National ...
... affiliated Life and Disability Companies are pleased to announce Newborn ... new mothers adjust to their newborn baby and return to ... to all new and in-force short term disability plans offered ... access to Newborn and Parenting Resources once their baby arrives ...
... LONDON, November 11 Extensive research conducted by ... of,Sheffield on the Simbionix PROcedure Rehearsal Studio(TM), was awarded ... congress in Lisbon, Portugal. , ... is,the world,s first patient specific system to enable clinicians ...
Cached Medicine News:Health News:Modern Wars, Modern Ills 2Health News:Modern Wars, Modern Ills 3Health News:Modern Wars, Modern Ills 4Health News:CHI's Molecular Medicine Tri-Conference Keynote John Crowley Inspires Feature Film Starring Harrison Ford 2Health News:CHI's Molecular Medicine Tri-Conference Keynote John Crowley Inspires Feature Film Starring Harrison Ford 3Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 2Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 3Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 4Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 5Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 6Health News:AEterna Zentaris Reports Third Quarter 2009 Financial and Operating Results 7Health News:WellPoint's Affiliated Life and Disability Companies Offer Newborn and Parenting Resources to Ease New Mothers' Transition Back to Work After Maternity Leave 2Health News:Research on Simbionix PROcedure Rehearsal Software Awarded Magna Cum Laude Prize at CIRSE 2009 2Health News:Research on Simbionix PROcedure Rehearsal Software Awarded Magna Cum Laude Prize at CIRSE 2009 3
(Date:11/18/2014)... Respiratory Motion and IMI Co announced today ... services providers in Japan , will ... respiratory depression monitor, the ExSpiron™. As part of this ... to connect the clinical community in promoting patient safety. ... innovative medical devices and new technology to the Japanese ...
(Date:11/18/2014)... and SAN DIEGO , ... HPPI), a clinical stage biopharmaceutical company that discovers, ... patients with cancer, announced today that it filed ... U.S. Food and Drug Administration (FDA) on Friday, ... covers HPPI,s proposed clinical development of a patented ...
(Date:11/18/2014)... Nov. 18, 2014 BioLink 2015, the ... Transfer Summit, co-organized by CCCMHPIE ( China Chamber ... Medicines & Health Products), UBM Live and Beijing ... 23rd, 2015 at Beijing Yizhuang Biomedical Park. ... This event will gather 200+ decision ...
Breaking Medicine Technology:Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 2Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 3Prominent Japanese Med Device Provider to be Respiratory Motion's Exclusive Partner for World's #2 Medical Market 4HedgePath Pharmaceuticals Files IND Application 2HedgePath Pharmaceuticals Files IND Application 3HedgePath Pharmaceuticals Files IND Application 4BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 2BioLink 2015 Will be Held on Jan 22, 2015, with a Focus on Biopharma Industrial Innovation & International Technology Transfer 3
... , , , , ... today issued the following letter to all shareholders. , , ... this letter is to update you on activities at the company. ... these letters as a means to provide insight to you on topical ...
... , , THOUSAND ... today announced that in a large, randomized, double-blind, placebo-controlled, Phase 3 ... anemia and type-2 diabetes (the T rial to R ... herapy, or TREAT), treatment of anemia with Aranesp((R) )(darbepoetin alfa) to ...
Cached Medicine Technology:Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 2Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 3Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 4Letter to Shareholders From Imagenetix, Inc. President/CEO William Spencer 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 2Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 3Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 4Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 5Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 6Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 7Amgen Announces Top-Line Results of Trial to Reduce Cardiovascular Events With Aranesp(R) Therapy (TREAT) in CKD Patients With Type-2 Diabetes 8
... is a stand-alone real-time monitoring, recording ... user defined set up, continuous monitoring ... and humidity. It offers non-restrictive sensor ... blood banks, laboratories, refrigerators, freezers, incubators ...
The ThermaViewer™ is constructed and engineered for use in laboratories, hospitals, and commercial kitchens to monitor and document freezer and refrigerator temperatures where inventory is store...
... tests confirmed Sterillium Rub's extremely effective and ... (Time Kill study and Tentative Final Monograph ... one European test - with the result ... efficacy specifications. Sterillium Rub with its high ...
... requiring no water for use, ... hygiene to physically clean hands ... either not an option or ... you to return to patient ...
Medicine Products: